Ruishan Liu
Overview
Explore the profile of Ruishan Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Wang J, Xu H, Qie Y, Han R, Sun X, Zhao Y, et al.
Front Genet
. 2024 Feb;
15:1342239.
PMID: 38327832
Powdery mildew is one of the most severe diseases affecting wheat yield and quality and is caused by f. sp. (). Host resistance is the preferred strategy to prevent this...
22.
Chen C, Yang F, Chen M, Xu Y, Xie Y, Liu R, et al.
Infect Drug Resist
. 2024 Jan;
17:51-59.
PMID: 38205063
Background: The emergence of the ST11-CRKP (ST11-CRKP) strain is expected to become a serious public health problem in China. As one of the most serious complications in patients with acute...
23.
Shao L, Liu X, Liu Y, Shen J, Liu R, Chen P
Pol J Microbiol
. 2023 Sep;
72(3):319-323.
PMID: 37725894
This work investigated the genetic relationship among strains in fecal samples from dairy cows in northeast China and identified the dominant β-lactamase genotype. One hundred and six samples were collected...
24.
Liu R, Li L, Wang L, Zhang S
Front Neurol
. 2023 Aug;
14:1198487.
PMID: 37602260
Background: The triglyceride-glucose index (TGI), a reliable surrogate indicator of insulin resistance (IR), has been proven to be a predictor of the incidence of ischemic stroke. The role of TGI...
25.
Qiao J, Chen Y, Ge H, Xu H, Guo X, Liu R, et al.
Front Microbiol
. 2023 Jun;
14:1074612.
PMID: 37378293
Purpose: To explore the genetic characteristics of the IMP-4, NDM-1, OXA-1, and KPC-2 co-producing multidrug-resistant (MDR) clinical isolate, wang9. Methods: MALDI-TOF MS was used for species identification. PCR and Sanger...
26.
Ge H, Qiao J, Zheng J, Xu H, Liu R, Zhao J, et al.
Ann Clin Microbiol Antimicrob
. 2023 Apr;
22(1):31.
PMID: 37120531
Background: Despite the global prevalence of Klebsiella pneumoniae Carbapenemase (KPC)-type class A β-lactamases, occurrences of KPC-3-producing isolates in China remain infrequent. This study aims to explore the emergence, antibiotic resistance...
27.
Hu X, Chen Y, Xu H, Qiao J, Ge H, Liu R, et al.
Sci Total Environ
. 2023 Apr;
882:163600.
PMID: 37086987
MCR-positive Escherichia coli (MCRPEC) have been reported in humans worldwide. The high prevalence of mcr-1 poses clinical and environmental risks due to its diverse genetic mechanisms. Given the vital role...
28.
Ge H, Qiao J, Xu H, Liu R, Zhao J, Chen R, et al.
Infect Drug Resist
. 2023 Apr;
16:1767-1775.
PMID: 37008750
Purpose: The frequent and inappropriate use of antibiotics has caused a dramatic rise in the number, species, and degree of multi-drug resistant bacteria, making them more prevalent and difficult to...
29.
Hu X, Zhang H, Liu Y, Liu X, Qiao J, Ge H, et al.
Front Microbiol
. 2023 Feb;
13:1055654.
PMID: 36726560
The emergence of carbapenemase significantly threatens public health. It is prevalent worldwide but rare in . Unlike most bacterial species, has two distinct flagella systems, which are closely related to...
30.
Liu R, Xu H, Zhao J, Hu X, Wu L, Qiao J, et al.
Virulence
. 2022 Dec;
14(1):233-245.
PMID: 36529894
Emerging mobile colistin resistance () genes pose a significant threat to public health for colistin was used as the last resort to treat multidrug-resistant (MDR) pathogenic bacterial infections. Hypervirulent (hvKP)...